ES2188611T3 - Empleo de granisetron para el tratamiento de las nauseas y vomitos postoperatorios. - Google Patents

Empleo de granisetron para el tratamiento de las nauseas y vomitos postoperatorios.

Info

Publication number
ES2188611T3
ES2188611T3 ES94911178T ES94911178T ES2188611T3 ES 2188611 T3 ES2188611 T3 ES 2188611T3 ES 94911178 T ES94911178 T ES 94911178T ES 94911178 T ES94911178 T ES 94911178T ES 2188611 T3 ES2188611 T3 ES 2188611T3
Authority
ES
Spain
Prior art keywords
vomites
nauseas
granisetron
operative
post
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94911178T
Other languages
English (en)
Inventor
Gareth John Smithkline Sanger
Philip Timothy Smithklin Davey
Christopher Stuart Dott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2188611(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2188611T3 publication Critical patent/ES2188611T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treatment Of Sludge (AREA)

Abstract

SE DESCRIBE EL USO DEL GRANISETRON EN LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LAS NAUSEAS Y VOMITOS POSOPERATORIOS (PONV).
ES94911178T 1993-03-18 1994-03-15 Empleo de granisetron para el tratamiento de las nauseas y vomitos postoperatorios. Expired - Lifetime ES2188611T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305593A GB9305593D0 (en) 1993-03-18 1993-03-18 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2188611T3 true ES2188611T3 (es) 2003-07-01

Family

ID=10732290

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94911178T Expired - Lifetime ES2188611T3 (es) 1993-03-18 1994-03-15 Empleo de granisetron para el tratamiento de las nauseas y vomitos postoperatorios.

Country Status (20)

Country Link
US (1) US5952340A (es)
EP (1) EP0689437B1 (es)
JP (2) JP3792251B2 (es)
KR (1) KR100315606B1 (es)
CN (1) CN1085079C (es)
AP (1) AP511A (es)
AT (1) ATE230596T1 (es)
AU (1) AU676032B2 (es)
CA (1) CA2158354C (es)
CY (1) CY2427B1 (es)
DE (1) DE69431986T2 (es)
DK (1) DK0689437T3 (es)
ES (1) ES2188611T3 (es)
GB (1) GB9305593D0 (es)
HU (1) HU214629B (es)
IL (1) IL109059A (es)
SG (1) SG46724A1 (es)
TW (1) TW312622B (es)
WO (1) WO1994021257A1 (es)
ZA (1) ZA941844B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412995D0 (en) * 1994-06-28 1994-10-26 Prendergast Kenneth F Safety enhancing pharmaceutical compositions of an active indazole
AU2003237657A1 (en) * 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
JP6081102B2 (ja) * 2012-08-10 2017-02-15 テルモ株式会社 安定なグラニセトロン含有水性製剤
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
JP2017077484A (ja) * 2016-11-30 2017-04-27 テルモ株式会社 安定なグラニセトロン含有水性製剤の包装体
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
ES2149767T5 (es) * 1991-09-20 2005-06-16 Glaxo Group Limited Nuevo uso medico para antagonistas de taquiquininas.

Also Published As

Publication number Publication date
US5952340A (en) 1999-09-14
ZA941844B (en) 1995-09-18
CY2427B1 (en) 2004-11-12
EP0689437B1 (en) 2003-01-08
WO1994021257A1 (en) 1994-09-29
HU9502692D0 (en) 1995-11-28
AU6377494A (en) 1994-10-11
TW312622B (es) 1997-08-11
HUT73502A (en) 1996-08-28
CA2158354C (en) 2004-07-13
DE69431986T2 (de) 2003-11-06
KR100315606B1 (ko) 2002-04-24
CN1122570A (zh) 1996-05-15
IL109059A (en) 1996-11-14
AU676032B2 (en) 1997-02-27
HK1012237A1 (en) 1999-07-30
AP511A (en) 1996-07-26
CA2158354A1 (en) 1994-09-29
IL109059A0 (en) 1994-11-28
GB9305593D0 (en) 1993-05-05
EP0689437A1 (en) 1996-01-03
DK0689437T3 (da) 2003-04-28
CN1085079C (zh) 2002-05-22
JPH08507774A (ja) 1996-08-20
JP3792251B2 (ja) 2006-07-05
JP2006083190A (ja) 2006-03-30
SG46724A1 (en) 1998-02-20
AP9400626A0 (en) 1994-04-30
ATE230596T1 (de) 2003-01-15
HU214629B (hu) 1998-04-28
DE69431986D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
AU618443B2 (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
YU15591A (sh) Novi potisni plinovi njihova upotreba u proizvodnji lekova
ES2127850T3 (es) Sulfonilaminopirimidinas, su obtencion y utilizacion como medicamentos.
FI942112L (fi) AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita
ATE183638T1 (de) Festes produkt zur behandlung von xerostomie
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
AR002254A1 (es) Formulacion antitrombotica y procedimiento para su manufactura
DK463989D0 (da) Farmaceutisk virksom kombination
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
ES2153820T3 (es) Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.
AR004510A1 (es) Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
DK0498841T3 (da) Bioklæbende middel og plaster
GR1001151B (el) Νεα xρηση θειορεδοξινης
ES2078904T3 (es) Nuevos derivados de neplanocina.
ES2098316T3 (es) Procedimiento de purificacion de carrageninas comerciales.
ES2061842T3 (es) Utilizacion del inhibidor de activador de plasminogeno (pai-2) para la inmunosupresion.
ES2101747T3 (es) Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.
ES2150547T3 (es) Uso de dimeticona para la fabricacion de un medicamento para el tratamiento de aftas y estomatitis.
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
CA2158354A1 (en) Use of granisetron for the treatment of post-operative nausea and vomiting
ES2058349T3 (es) Utilizacion de betabloqueadores para el tratamiento de la progresion de la miopia axial infantil.
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
MX9301879A (es) Medicamento para el tratamiento de la inflamacion de las vias respiratorias
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche